These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32683456)

  • 1. COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan.
    Zhou X; Bai T; Meckel K; Song J; Jin Y; Kortüm KM; Einsele H; Hou X; Rasche L
    Ann Hematol; 2021 Mar; 100(3):843-846. PubMed ID: 32683456
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.
    Djebbari F; Panitsas F; Sharpley FA; Rampotas A; Larham J; Moore S; Gooding S; Kothari J; Ramasamy K
    Eur J Haematol; 2020 Nov; 105(5):662-666. PubMed ID: 32592210
    [No Abstract]   [Full Text] [Related]  

  • 3. Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.
    Kocoglu MH; Richardson PG; Mo CC; Rapoport AP; Atanackovic D
    Haematologica; 2024 Jul; 109(7):2372-2377. PubMed ID: 38385273
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies.
    Ghione P; Gu JJ; Attwood K; Torka P; Goel S; Sundaram S; Mavis C; Johnson M; Thomas R; McWhite K; Darrall A; DeMarco J; Kostrewa J; Mohr A; Rivas L; Neiders M; Suresh L; Segal BH; Griffiths EA; Ramsperger V; Shen L; Hernandez-Ilizaliturri FJ
    Blood; 2021 Sep; 138(9):811-814. PubMed ID: 34189565
    [No Abstract]   [Full Text] [Related]  

  • 5. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Diorio C; Anderson EM; McNerney KO; Goodwin EC; Chase JC; Bolton MJ; Arevalo CP; Weirick ME; Gouma S; Vella LA; Henrickson SE; Chiotos K; Fitzgerald JC; Kilbaugh TJ; John ARO; Blatz AM; Lambert MP; Sullivan KE; Tartaglione MR; Zambrano D; Martin M; Lee JH; Young P; Friedman D; Sesok-Pizzini DA; Hensley SE; Behrens EM; Bassiri H; Teachey DT
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28693. PubMed ID: 32885904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.
    Zeng F; Dai C; Cai P; Wang J; Xu L; Li J; Hu G; Wang Z; Zheng F; Wang L
    J Med Virol; 2020 Oct; 92(10):2050-2054. PubMed ID: 32383183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.
    Ludwig H; San-Miguel J; Munshi N; Sonneveld P; Mateos MV; Moreau P; Terpos E
    Am J Hematol; 2021 Aug; 96(8):896-900. PubMed ID: 34057243
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies who recovered from SARS-COV-2 infection.
    Candoni A; Pizzano U; Fabris M; Curcio F; Fanin R
    Hematol Oncol; 2021 Aug; 39(3):428-431. PubMed ID: 33951220
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020.
    Han H; Yi J; Cheng G; Jiang W; Brożek GM; Jiang Y; Zhu C; Xia Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.
    Shang Y; Liang Y; Liu T; Li J; Zhou F
    J Med Virol; 2022 Apr; 94(4):1535-1539. PubMed ID: 34850404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
    Gastinne T; Le Bourgeois A; Coste-Burel M; Guillaume T; Peterlin P; Garnier A; Imbert BM; Drumel T; Mahe B; Dubruille V; Blin N; Lok A; Touzeau C; Tessoulin B; Jullien M; Vanthygem S; Béné MC; Moreau P; Le Gouill S; Chevallier P
    Br J Haematol; 2022 Jan; 196(2):360-362. PubMed ID: 34476803
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of antibodies against SARS-CoV-2 in patients with COVID-19.
    Du Z; Zhu F; Guo F; Yang B; Wang T
    J Med Virol; 2020 Oct; 92(10):1735-1738. PubMed ID: 32243608
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serosurvey of SARS-CoV-2 among hospital visitors in China.
    Liang W; Lin Y; Bi J; Li J; Liang Y; Wong SS; Zanin M; Yang Z; Li C; Zhong R; Jiang G; Han G; Hu D; He J; Zhong N
    Cell Res; 2020 Sep; 30(9):817-818. PubMed ID: 32686766
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust and sustained antibody response to SARS-CoV-2 in a child pre and post autologous hematopoietic stem cell transplant.
    Gupta AK; Ramachandran M; Meena JP; Dwivedi T; Singh U; Gupta R; Seth R
    Pediatr Blood Cancer; 2021 May; 68(5):e28848. PubMed ID: 33351985
    [No Abstract]   [Full Text] [Related]  

  • 19. Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
    Terpos E; Trougakos IP; Gavriatopoulou M; Papassotiriou I; Sklirou AD; Ntanasis-Stathopoulos I; Papanagnou ED; Fotiou D; Kastritis E; Dimopoulos MA
    Blood; 2021 Jul; 137(26):3674-3676. PubMed ID: 33861315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.